It's a shelf registration, and the shares will be sold by Geron...
Notice the proviso that ML can buy up to 15% of the offering...
And why oh why would the price be rising now..?
Cause now Geron has signaled that they do not need pharma and can go at this alone.
Cause the market knows this is for real.
This is what I have personally been hoping for.
If Geron would have sold out to big pharma, I was going to use those proceeds to invest in whatever company ended up with this science. But knew the gains would be limited.
My hope and dream is that I would watch the company come to market with their own products and make the most from them...
...this has now been confirmed, by the offering, in many people's eyes, considering the stage and results of the recent trials.
in my opinion...
News 
Market Data 
Discover 
AI
